ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항염증약 시장 규모는 앞으로 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.8%로 성장할 전망이며, 2,288억 3,000만 달러로 성장이 예측됩니다. 예측 기간에 성장의 원동력은 자가면역 질환의 이환율 상승, 맞춤형 의료에 대한 수요 증가, 노인 증가, 정부의 지원책, 국소요법 및 표적요법에 대한 기호의 고조에 있는 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 생물제제 혁신, 생물제제 및 바이오시밀러로의 이동, 원격의료 기반의 배합 증가, 창약에 있어서 인공지능의 통합, 신규 항염증 메커니즘의 연구개발의 진행, 표적 항염증 요법의 진보 등이 있습니다.
관절염의 유병률 증가는 앞으로 수년간 항염증약 시장의 성장을 가속할 것으로 예측됩니다. 관절염은 하나 이상의 관절의 염증을 특징으로 하며, 통증, 붓기, 경직을 일으키고 나이가 들면서 악화되는 경우가 많습니다. 관절염의 개발은 인구 고령화가 주요 원인이며, 시간이 지남에 따라 관절의 자연적인 마모 및 손상이 이 증상의 발병 위험을 높이기 때문입니다. 항염증약는 관절염 관리에 중요한 역할을 하며, 관절의 염증과 통증을 줄이고, 환자가 가동성을 유지하고, 일상생활을 보다 쾌적하게 할 수 있도록 지원해, 전체적인 생활의 질을 향상시킵니다. 예를 들어, 2023년 3월 영국 정부 기관인 Office for Health Improvement and Disparities는 2022년에는 16세 이상의 17.6%가 관절염과 지속적인 관절과 등 문제 등 장기적인 근골격계(MSK) 질환을 가지고 있으며, 2021년 17.0%에서 증가했습니다. 따라서 관절염의 유병률 증가는 항염증약 시장의 성장에 크게 기여합니다.
항염증약 시장의 주요 기업은 표적 약물 전달을 개선하고 환자의 컴플라이언스를 높이기 위해 외용액제 등의 혁신적인 제제의 개발에 주력하고 있습니다. 외용액이란 피부나 환부에 직접 도포하는 액상의 약제를 말하며, 전신적인 부작용을 최소화하면서 유효성분을 염증 부위에 국소적으로 작용시킬 수 있습니다. 예를 들면, 2022년 12월, 인도의 제약 회사 루핀 리미티드는, 미국 호라이즌 파마 세라퓨틱스의 펜사이드(디클로페낙 나트륨 외용액, 2% w/w)의 정규 제네릭 의약품을 발매했습니다. 이는 루핀의 미국 제네릭 의약품 포트폴리오를 확대하고 저렴한 항염증 치료에 대한 접근성을 개선하는 것을 목적으로 하고 있습니다. 이 약물은 비스테로이드성 항염증약으로 변형성 무릎관절증으로 인한 통증 완화에 사용되며, 국소적인 도포로 국소적인 완화를 초래하고 경구 비스테로이드성 항염증약에 따른 전신적인 위험을 줄여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 항염증약 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 항염증약 시장 : 성장률 분석
세계의 항염증약 시장 실적 : 규모 및 성장(2019-2024년)
세계의 항염증약 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 항염증약 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 항염증약 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
스테로이드
비스테로이드성 항염증약(NSAIDs)
생물제제와 바이오시밀러
기타 약품 클래스
세계의 항염증약 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
비경구
경구
국소
흡입
세계의 항염증약 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
자가면역 질환
호흡기 질환
기타
세계의 항염증약 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 항염증약 시장 : 스테로이드별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
미네랄 코르티코이드
세계의 항염증약 시장 : 비스테로이드성 항염증약(NSAIDs)별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
비선택적 비스테로이드성 항염증약(NSAIDs)
선택적 시클로옥시게나제-2(COX-2) 억제제
세계의 항염증약 시장 : 바이오 의약품 및 바이오 시밀러별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양괴사인자(TNF) 억제제
인터루킨(IL) 억제제
야누스 키나아제(JAK) 억제제
세계의 항염증약 시장 : 기타 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
질환 수식성 항류마티스약(DMARD)
면역억제제
항히스타민제
제7장 지역별 및 국가별 분석
세계의 항염증약 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항염증약 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
항염증약 시장 : 경쟁 구도
항염증약 시장 : 기업 프로파일
Merck & Co. Inc.
AbbVie Inc.
Bayer AG
Novartis AG
Sanofi SA
제31장 기타 주요 기업 및 혁신 기업
Bristol-Myers Squibb Company
AstraZeneca plc
Gilead Sciences Inc.
Amgen Inc.
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Vertex Pharmaceuticals Inc.
UCB SA
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
Cipla Limited
Cadila Pharmaceuticals
Samsung Bioepis
Lupin Limited
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
항염증약 시장(2029년) : 새로운 기회를 제공하는 국가
항염증약 시장(2029년) : 새로운 기회를 제공하는 부문
항염증약 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Anti-inflammatory drugs are a category of medications designed to alleviate inflammation, pain, fever, and swelling by disrupting the body's natural inflammatory processes. They function by blocking the activity or production of chemical messengers like prostaglandins, leukotrienes, and cytokines, which play key roles in initiating and maintaining inflammation.
The primary classes of anti-inflammatory drugs include steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics and biosimilars, among others. Steroids, which imitate natural hormones, are commonly used to manage conditions such as asthma, arthritis, and allergies. These medications can be administered in various forms, including parenteral, oral, topical, and inhalation routes. They are employed in the treatment of multiple conditions, including autoimmune and respiratory diseases. Anti-inflammatory drugs are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory drugs market statistics, including anti-inflammatory drugs industry global market size, regional shares, competitors with the anti-inflammatory drugs market share, anti-inflammatory drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-inflammatory drugs industry. This anti-inflammatory drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anti-inflammatory drugs market size has grown rapidly in recent years. It will grow from $136.86 billion in 2024 to $152.08 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. Growth during the historic period can be attributed to several key factors, including an aging population, the increasing prevalence of chronic inflammatory diseases, greater over-the-counter availability of medications, rising awareness of pain management, and the expansion of healthcare infrastructure.
The anti-inflammatory drugs market size is expected to see rapid growth in the next few years. It will grow to $228.83 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. Growth in the forecast period is expected to be driven by the rising incidence of autoimmune diseases, increasing demand for personalized medicine, a growing geriatric population, supportive government initiatives, and a rising preference for topical and targeted therapies. Key trends anticipated during this period include innovations in biologic drugs, a shift toward biologics and biosimilars, the rise of telemedicine-based prescriptions, the integration of artificial intelligence in drug discovery, ongoing research and development of novel anti-inflammatory mechanisms, and advancements in targeted anti-inflammatory therapies.
The increasing prevalence of arthritis is expected to drive the growth of the anti-inflammatory drugs market in the coming years. Arthritis is characterized by inflammation in one or more joints, leading to pain, swelling, and stiffness that often worsens with age. The growing incidence of arthritis is largely attributed to aging populations, as the natural wear and tear on joints over time raises the risk of developing the condition. Anti-inflammatory drugs play a key role in managing arthritis by reducing joint inflammation and pain, helping patients maintain mobility, perform daily activities more comfortably, and improve their overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK government department, reported that in 2022, 17.6% of individuals aged 16 and above had a long-term musculoskeletal (MSK) condition-such as arthritis or persistent joint or back issues-an increase from 17.0% in 2021. Thus, the rising prevalence of arthritis is contributing significantly to the growth of the anti-inflammatory drugs market.
Leading companies in the anti-inflammatory drugs market are focusing on developing innovative formulations, such as topical solutions, to improve targeted drug delivery and enhance patient compliance. A topical solution is a liquid form of medication applied directly to the skin or affected area, allowing the active ingredients to act locally at the site of inflammation while minimizing systemic side effects. For example, in December 2022, Lupin Limited, an India-based pharmaceutical company, launched the authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the United States. This move aimed to expand Lupin's U.S. generics portfolio and improve access to affordable anti-inflammatory treatments. The drug, a nonsteroidal anti-inflammatory agent, is used to relieve pain caused by osteoarthritis of the knee, offering localized relief through topical application and reducing the systemic risks associated with oral NSAIDs.
In March 2022, Pfizer, a U.S.-based pharmaceutical company, acquired Arena Pharmaceuticals for approximately $6.7 billion. This acquisition was intended to strengthen Pfizer's pipeline of potential therapies targeting immuno-inflammatory diseases, with a focus on areas such as gastroenterology, dermatology, and cardiology. Arena Pharmaceuticals, also based in the U.S., is a clinical-stage company dedicated to developing innovative treatments for a range of immuno-inflammatory conditions.
Major players in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited.
North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-inflammatory drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anti-inflammatory drugs market consists of sales of immunosuppressants, COX-2 inhibitors, interleukin inhibitors, and TNF-alpha inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Inflammatory Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anti-inflammatory drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anti-inflammatory drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-inflammatory drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Steroids; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Biologics And Biosimilars; Other Drug Classes
2) By Route of Administration: Parenteral; Oral; Topical; Inhalation
3) By Applications: Autoimmune Diseases; Respiratory Diseases; Other Diseases
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids; Mineralocorticoids
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anti-Inflammatory Drugs Market Characteristics
3. Anti-Inflammatory Drugs Market Trends And Strategies
4. Anti-Inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Anti-Inflammatory Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Anti-Inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anti-Inflammatory Drugs Market Growth Rate Analysis
5.4. Global Anti-Inflammatory Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anti-Inflammatory Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anti-Inflammatory Drugs Total Addressable Market (TAM)
6. Anti-Inflammatory Drugs Market Segmentation
6.1. Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Steroids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics And Biosimilars
Other Drug Classes
6.2. Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
Topical
Inhalation
6.3. Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autoimmune Diseases
Respiratory Diseases
Other Diseases
6.4. Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Mineralocorticoids
6.6. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.7. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors
Interleukin (IL) Inhibitors
Janus Kinase (JAK) Inhibitors
6.8. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Immunosuppressants
Antihistamines
7. Anti-Inflammatory Drugs Market Regional And Country Analysis
7.1. Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anti-Inflammatory Drugs Market
9.1. China Anti-Inflammatory Drugs Market Overview
9.2. China Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anti-Inflammatory Drugs Market
10.1. India Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anti-Inflammatory Drugs Market
11.1. Japan Anti-Inflammatory Drugs Market Overview
11.2. Japan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anti-Inflammatory Drugs Market
12.1. Australia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anti-Inflammatory Drugs Market
13.1. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anti-Inflammatory Drugs Market
14.1. South Korea Anti-Inflammatory Drugs Market Overview
14.2. South Korea Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anti-Inflammatory Drugs Market
15.1. Western Europe Anti-Inflammatory Drugs Market Overview
15.2. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anti-Inflammatory Drugs Market
16.1. UK Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anti-Inflammatory Drugs Market
17.1. Germany Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anti-Inflammatory Drugs Market
18.1. France Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anti-Inflammatory Drugs Market
19.1. Italy Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anti-Inflammatory Drugs Market
20.1. Spain Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anti-Inflammatory Drugs Market
21.1. Eastern Europe Anti-Inflammatory Drugs Market Overview
21.2. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anti-Inflammatory Drugs Market
22.1. Russia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anti-Inflammatory Drugs Market
23.1. North America Anti-Inflammatory Drugs Market Overview
23.2. North America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anti-Inflammatory Drugs Market
24.1. USA Anti-Inflammatory Drugs Market Overview
24.2. USA Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anti-Inflammatory Drugs Market
26.1. South America Anti-Inflammatory Drugs Market Overview
26.2. South America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anti-Inflammatory Drugs Market
27.1. Brazil Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anti-Inflammatory Drugs Market
28.1. Middle East Anti-Inflammatory Drugs Market Overview
28.2. Middle East Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anti-Inflammatory Drugs Market
29.1. Africa Anti-Inflammatory Drugs Market Overview
29.2. Africa Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anti-Inflammatory Drugs Market Competitive Landscape And Company Profiles
